Skip to main content

Retail brokerage TD Ameritrade Holding Corp said on Wednesday it has invested in a new cryptocurrency exchange called ErisX in a bid to offer clients digital asset investment options beyond the popular bitcoin.

TD Ameritrade clients can already trade bitcoin futures over the CBOE Futures Exchange. ErisX will allow clients to potentially trade other cryptocurrency futures, such as Etherium and Litecoin, said J.B. Mackenzie, TD Ameritrade’s managing director of futures and foreign exchange.

“It could open up additional cryptocurrency products on the future and spot side that our clients could potentially trade,” Mackenzie said.

Story continues below advertisement

Cryptocurrencies are virtual tokens that can be used as forms of payments on a variety of online applications. They can also be traded on dedicated online exchanges.

ErisX plans to launch spot trading in the first half of 2019, with physically settled futures to launch later in 2019, subject to regulatory approval, said ErisX Chief Executive Officer Thomas Chippas.

TD Ameritrade did not disclose the size of its investment in ErisX. It joins more than a dozen other investors, including Virtu Financial Inc, Cboe Global Markets Inc and Digital Currency Group in contributing to the funding round.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies